https://www.selleckchem.com/products/reacp53.html
7% (1/6) RTRs in the nystatin group (P=1.0. All RTRs with OC achieved symptom resolution with fluconazole and/or nystatin. Two patients in the No PPX group required readmission for decreased oral intake, and OC was diagnosed and treated during their hospital day. In this retrospective study of adult RTRs, the absence of antifungal prophylaxis demonstrated non-inferiority to 30-day nystatin prophylaxis at reducing the incidence of OC within 3months of transplant. OC prophylaxis may not be warranted after renal transplant. In this retro
Curtir
Comentario
Compartilhar
